Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 6 of 6
EC Number Crystallization (Commentary)
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22-
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22core domain, to 1.8 A resolution. Three dimers per asymmetric unit. Molecular replacement carried out using the AroDC structure as a model
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22crystal structure at 3.0 A resolution
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22crystal structure of active HDC at pH 4.8 at 2.5 A resolution, crystal structure of less active HDC at pH 8.0 at 2.7 A resolution, crystals are grown at room temperatur by hanging-drop vapor diffusion, drops contain 0.004 ml HDC at 12.5 mg/ml, 0.001 ml n-dodecyl-beta-D-maltoside and 0.005 ml precipitant solution from the well containing 25% polyethylene glycol 400, 8% polyethylene glycol 400, 100 mM Tris pH 8.0, and 100 mM sodium acetate, enzyme activity is regulated by pH-induced structural changes
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22in complex with the inhibitor histidine methyl ester, to 1.8 A resolution. Cofactor pyridoxal 5'-phosphate is located in the large domain. The pyridine ring of pyridoxal 5'-phosphate is sandwiched between the methyl group of Ala275 and the imidazole ring of His194. Residue Ser354 is a key residue for substrate specificity
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22modeling of complex with inhibitor epigallocatechin-3-gallate. The presence of epigallocatechin-3-gallate contiguous to the active site entrance leads to the movement of several residues in the active site. Epigallocatechin-3-gallate occludes the entrance channel to the enzyme active site and establishes new interactions with residues in the active site. These residues turn outward when the active site collapses
Results 1 - 6 of 6